एपीए उद्धरण

McKeage, M. J., Jameson, M. B., Ramanathan, R. K., Rajendran, J., Gu, Y., Wilson, W. R., . . . Tchekmedyian, N. S. (2012). PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours. BioMed Central.

शिकागो स्टाइल उद्धरण

McKeage, Mark J., Michael B. Jameson, Ramesh K. Ramanathan, Joseph Rajendran, Yongchuan Gu, William R. Wilson, Teresa J. Melink, और N Simon Tchekmedyian. PR-104 a Bioreductive Pre-prodrug Combined With Gemcitabine or Docetaxel in a Phase Ib Study of Patients With Advanced Solid Tumours. BioMed Central, 2012.

एमएलए उद्धरण

McKeage, Mark J., et al. PR-104 a Bioreductive Pre-prodrug Combined With Gemcitabine or Docetaxel in a Phase Ib Study of Patients With Advanced Solid Tumours. BioMed Central, 2012.